
The Federal Government has pushed for new studies and additional funding with the goal of finding effective treatment for the disease by 2025.
Alzheimer’s research gets a new push with new federal government funding and support for experimental treatments.
Alzheimer's research got a boost Tuesday after the federal government announced new funding and support to combat the disease.
Health Secretary Kathleen Sebelius said that the new National Alzheimer's Plan would seek to find effective treatment for the illness by 2025.
MedPade Today reported that the 2012 budget contained about $500 million toward with the disease with Obama administration earmarking about $100 million in the 2013 budget.
The bulk of the money will go toward clinical research with the rest toward awareness campaigns and to caregivers.
The federal government said that a website would be launched on Tuesday for sufferers and their families to find out treatment options and other information.
"These actions are the cornerstones of an historic effort to fight Alzheimer's disease," said US Health Secretary Kathleen Sebelius at a meeting of Alzheimer's researchers, reported the Associated Press.
Read more on GlobalPost: Dementia cases will triple by 2050, World Health Organization report finds
Reuters reported that the new plan would also back research into preventative drugs such as crenezumab.
The federal government announced plans to fund a study of the drug in Colombia, in a community that contains genes predisposed for the illness.
“Clinical trials will be done at a time when a patient has no symptoms. We’re trying to stop or slow the onset of the disease in this group of patients,” said Richard Scheller, executive vice president of research and development at Genentech, the company that created the new drug, reported ABC News.
“We know when they will contract the disease because of the numerous studies that have been done on the mutation."
It is estimated that over five million Americans suffer from the disease and 35 million people worldwide.
According to Alzheimer's Disease International, the number of people with the disease is set to double every 20 years.